Trial in Progress Update on Engotcx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin - Bevacizumab in Recurrentimetastatic Cervical Cancer

dc.contributor.authorVergote, Ignace
dc.contributor.authorMirza, Mansoor
dc.contributor.authorSehouli, Jalid
dc.contributor.authorLorusso, Domenico
dc.contributor.authorKose, Fatih
dc.contributor.authorCibula, David
dc.contributor.authorWestermann, Anneke
dc.contributor.authorCollins, Dearbhaile
dc.contributor.authorBanerjee, Susana
dc.contributor.authorOaknin, Ana
dc.contributor.authorSoumaoro, Ibrahima
dc.contributor.authorJain, Shweta
dc.contributor.authorMonk, Bradley J.
dc.date.accessioned2023-09-15T12:47:14Z
dc.date.available2023-09-15T12:47:14Z
dc.date.issued2022
dc.identifier.eissn1525-1438en_US
dc.identifier.endpageA64en_US
dc.identifier.issn1048-891Xen_US
dc.identifier.issueSupplement 2en_US
dc.identifier.startpageA64en_US
dc.identifier.urihttps://ijgc.bmj.com/content/ijgc/32/Suppl_2/A64.1.full.pdf
dc.identifier.urihttp://hdl.handle.net/11727/10676
dc.identifier.volume32en_US
dc.identifier.wos000899077700139en_US
dc.language.isoengen_US
dc.relation.isversionof10.1136/ijgc-2022-ESGO.139en_US
dc.relation.journalINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCERen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleTrial in Progress Update on Engotcx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin - Bevacizumab in Recurrentimetastatic Cervical Canceren_US
dc.typeConference Objecten_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ae34.pdf
Size:
75.46 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: